IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q2 2017 Holdings

Filed 2017-08-14 | 15 holdings | $11.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Conmed Corp(CNMD)COM207410101$11.5M226,49797.3%
Bioverativ IncCOM97075E100$42.6K708,7540.4%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$39.8K1,104,9920.3%
Gilead Sciences Inc(GILD)COM375558103$37.7K532,4340.3%
United Therapeutics Corp(UTHR)COM91307C102$35.4K272,9960.3%
Sucampo PharmaceuticalsCOM864909106$29.6K2,819,7080.2%
Orthofix International NVCOMN6748L102$27.1K583,8070.2%
RTI Surgical IncCOM74975N105$26.1K4,465,0860.2%
Merck & Co. Inc.(MRK)COM58933Y105$24.5K382,4340.2%
Halyard Health IncCOM40650V100$22.4K570,9640.2%
Invacare CorpCOM461203101$14.8K1,121,0660.1%
Amgen IncCOM90478E103$13.3K77,0790.1%
Aviragen Therapeutics IncCOM053761102$1.9K2,836,3260.0%
Digirad CorpCOM253827109$1.4K334,1790.0%
Juniper Pharmaceuticals IncCOM48203L107$1.2K243,1280.0%